DCM Shriram Ltd
DCM Shriram Ltd
DiversifiedKey Fundamentals
SmallcapDiversified GroupDiversifiedInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view DCM Shriram Ltd insights
40 extracted metrics + investor summaries across FY14–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 22.4%
Weaknesses
4- The company has delivered a poor sales growth of 10.3% over past five years.
- Tax rate seems low
- Company has a low return on equity of 8.95% over last 3 years.
- Company might be capitalizing the interest cost
Growth Rate
AI Analysis — Bull vs Bear
DCM Shriram Ltd is a diversified conglomerate trading at a PE of 10.8x with a market cap of Rs 15,600 Cr. The company has shown a sharp TTM profit recovery of 122% but carries a muted 3-year profit CAGR of -1% and a below-average 3-year ROE of 9%, reflecting cyclicality in its core chemicals and sugar businesses.
- TTM profit growth of 122% signals a strong earnings recovery from a cyclical trough
- PE of 10.8x is well below the broader market average, suggesting undemanding valuations for a diversified business
- 10-year compounded profit growth of 11% demonstrates long-term earnings compounding capability
- 10-year stock CAGR of 16% shows meaningful long-term wealth creation for shareholders
- TTM sales growth of 11% indicates improving top-line momentum versus 5-year CAGR of 10%
- Consistent dividend payout of 22.4% with a current yield of 1.13% provides a floor of shareholder returns
- Price-to-book of 2.01x is reasonable for a company with diversified asset-heavy operations across chemicals, sugar, and fertilizers
- 5-year ROE of 12% and 10-year ROE of 15% show the business can generate attractive returns across full cycles
- Stock has declined 25% over the past 1 year, indicating sustained negative sentiment or earnings downgrades
- 3-year compounded profit growth of -1% highlights earnings volatility and cyclical vulnerability
- 3-year ROE of only 9% is below the cost of equity for most investors, indicating subpar capital efficiency in recent years
- 5-year sales CAGR of only 10.3% is considered poor for a mid-cap diversified company
- Concern around possible capitalization of interest costs, which could overstate reported profitability and asset values
- Apparently low tax rate raises questions about sustainability of reported earnings and potential future tax normalization
- 3-year stock CAGR of just 3% and 5-year CAGR of 1% show prolonged period of shareholder value stagnation
- Last year ROE of 12% remains below the 10-year average of 15%, suggesting the business has not fully recovered to historical profitability norms
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- PAT surges 42% in FY26 Jul 21
DCM Shriram reported consolidated net revenue of ₹13,538 crore in FY26 (up from ₹12,077 crore) with net profit rising 42% to ₹856 crore. Chemicals segment led growth with 31% revenue increase.
- Q1FY27 PAT up 509% YoY Jul 28
Net profit jumped 509% YoY to ₹693 crore in Q1FY27, driven by a ₹474 crore tax adjustment. Revenue rose 9% to ₹3,564 crore and EBITDA margin expanded to 8.88% from 8.80%.
- ESG improvement, zero fatalities Jul 21
DCM Shriram filed its BRSR for FY26 reporting a 6% reduction in energy intensity, zero fatalities, and an ESG score of 63.
- Two independent directors retire Aug 8
Mr. Pravesh Sharma and Justice (Retd.) Vikramajit Sen complete their second term as Independent Directors, ceasing roles effective 9th August 2026.
- Q1FY27 earnings call hosted Jul 30
DCM Shriram hosted its analyst earnings call on July 30, 2026 at 4:00 PM IST to discuss Q1 FY27 unaudited standalone and consolidated results.
TL;DR: DCM Shriram is delivering strong earnings momentum with FY26 PAT up 42% and Q1FY27 showing robust revenue growth of 9%, though headline profit was inflated by a one-time ₹474 crore tax gain. The chemicals segment is a clear growth driver with 31% revenue increase. No material headwinds are visible in recent news flow, and ESG metrics are improving. The trend is positive, but investors should monitor whether normalized profitability sustains beyond tax-related boosts.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,780 | 2,708 | 3,035 | 2,399 | 2,876 | 2,957 | 3,367 | 2,877 | 3,262 | 3,272 | 3,811 | 3,193 | 3,564 |
| Expenses | 2,614 | 2,594 | 2,590 | 2,134 | 2,629 | 2,776 | 2,871 | 2,472 | 2,958 | 2,963 | 3,280 | 2,840 | 3,228 |
| Operating Profit | 166 | 114 | 445 | 265 | 248 | 181 | 496 | 405 | 304 | 309 | 532 | 353 | 337 |
| OPM % | 6% | 4.2% | 15% | 11% | 9% | 6% | 15% | 14% | 9% | 9% | 14% | 11% | 9% |
| Other Income | 17 | 22 | 35 | 24 | 26 | 54 | 41 | 21 | 22 | 99 | -26 | 78 | 107 |
| Interest | 25 | 15 | 15 | 32 | 29 | 38 | 43 | 43 | 44 | 43 | 49 | 40 | 41 |
| Depreciation | 72 | 74 | 77 | 80 | 86 | 101 | 109 | 114 | 112 | 119 | 134 | 138 | 128 |
| PBT | 86 | 47 | 389 | 177 | 158 | 96 | 386 | 270 | 170 | 246 | 322 | 254 | 274 |
| Tax % | 34% | 32% | 38% | 33% | 37% | 34% | 32% | 34% | 33% | 35% | 34% | -46% | -152% |
| Net Profit | 57 | 32 | 240 | 118 | 100 | 63 | 262 | 179 | 114 | 159 | 213 | 371 | 693 |
| EPS in Rs | 3.63 | 2.07 | 15.42 | 7.55 | 6.43 | 4.03 | 16.81 | 11.47 | 7.27 | 10.13 | 13.6 | 23.72 | 44.42 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,639 | 5,780 | 5,788 | 6,900 | 7,771 | 7,767 | 8,308 | 9,627 | 11,547 | 10,922 | 12,077 | 13,538 | 13,840 |
| Expenses | 5,240 | 5,276 | 5,017 | 5,866 | 6,402 | 6,575 | 7,156 | 7,831 | 9,941 | 9,932 | 10,747 | 12,041 | 12,310 |
| Operating Profit | 399 | 505 | 771 | 1,035 | 1,369 | 1,192 | 1,152 | 1,796 | 1,606 | 991 | 1,330 | 1,497 | 1,530 |
| OPM % | 7% | 9% | 13% | 15% | 18% | 15% | 14% | 19% | 14% | 9% | 11% | 11% | 11% |
| Other Income | 52 | 41 | 47 | 56 | 88 | 88 | 92 | 92 | 120 | 99 | 142 | 173 | 258 |
| Interest | 112 | 85 | 71 | 83 | 119 | 164 | 122 | 85 | 53 | 88 | 153 | 176 | 173 |
| Depreciation | 110 | 98 | 114 | 141 | 157 | 219 | 233 | 238 | 260 | 303 | 410 | 502 | 519 |
| PBT | 228 | 362 | 633 | 867 | 1,180 | 897 | 889 | 1,565 | 1,413 | 699 | 909 | 992 | 1,096 |
| Tax % | 8% | 17% | 13% | 23% | 24% | 20% | 24% | 32% | 36% | 36% | 34% | 14% | — |
| Net Profit | 211 | 301 | 552 | 669 | 904 | 722 | 674 | 1,067 | 911 | 447 | 604 | 856 | 1,436 |
| EPS in Rs | 12.98 | 18.58 | 33.97 | 41.22 | 56.99 | 45.96 | 43.17 | 68.45 | 58.41 | 28.67 | 38.75 | 54.73 | 91.87 |
| Div. Payout % | 17% | 17% | 17% | 20% | 17% | 18% | 22% | 22% | 24% | 23% | 23% | 21% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 33 | 33 | 33 | 33 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 1,826 | 2,058 | 2,495 | 3,007 | 3,494 | 4,018 | 4,617 | 5,470 | 6,162 | 6,491 | 6,973 | 7,681 |
| Borrowings | 760 | 1,064 | 1,074 | 756 | 1,610 | 2,150 | 1,521 | 1,577 | 1,707 | 2,152 | 2,529 | 2,923 |
| Other Liabilities | 1,798 | 1,852 | 1,972 | 1,857 | 2,001 | 1,935 | 1,621 | 2,290 | 2,819 | 2,874 | 3,198 | 3,479 |
| Total Liabilities | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,731 | 14,115 |
| Fixed Assets | 1,443 | 1,428 | 2,022 | 2,211 | 2,690 | 3,499 | 3,360 | 3,408 | 4,105 | 4,222 | 6,517 | 7,518 |
| CWIP | 62 | 357 | 65 | 117 | 332 | 59 | 109 | 494 | 1,630 | 2,615 | 834 | 571 |
| Investments | 6 | 35 | 31 | 30 | 31 | 29 | 30 | 3 | 12 | 54 | 56 | 136 |
| Other Assets | 2,906 | 3,186 | 3,457 | 3,294 | 4,084 | 4,548 | 4,291 | 5,463 | 4,973 | 4,656 | 5,324 | 5,889 |
| Total Assets | 4,417 | 5,007 | 5,574 | 5,652 | 7,136 | 8,135 | 7,790 | 9,369 | 10,720 | 11,547 | 12,731 | 14,115 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 167 | 100 | 772 | 827 | 775 | 496 | 1,887 | 1,224 | 1,296 | 794 | 1,127 | 1,234 |
| Investing | 228 | -326 | -411 | -321 | -803 | -518 | -642 | -888 | -1,543 | -1,070 | -850 | -1,241 |
| Financing | -594 | 166 | -185 | -571 | 277 | 183 | -918 | -275 | -235 | 169 | -1 | -307 |
| Net Cash Flow | -200 | -59 | 176 | -65 | 248 | 161 | 327 | 62 | -482 | -107 | 277 | -314 |
| Free Cash Flow | 115 | -249 | 331 | 440 | -73 | -102 | 1,642 | 478 | -493 | -514 | 280 | 354 |
| CFO/OP | 56 | 36 | 119 | 102 | 76 | 55 | 178 | 84 | 101 | 100 | 92 | 88 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 81 | 63 | 48 | 49 | 51 | 23 | 34 | 27 | 22 | 28 | 29 |
| Inventory Days | 120 | 141 | 194 | 163 | 190 | 208 | 146 | 190 | 153 | 168 | 162 | 162 |
| Days Payable | 119 | 123 | 138 | 110 | 113 | 89 | 57 | 79 | 65 | 65 | 69 | 64 |
| Cash Conversion Cycle | 71 | 100 | 120 | 100 | 126 | 170 | 111 | 145 | 115 | 124 | 121 | 128 |
| Working Capital Days | 43 | 31 | 35 | 57 | 48 | 52 | 44 | 45 | 37 | 34 | 26 | 25 |
| ROCE % | 12% | 15% | 21% | 25% | 29% | 19% | 16% | 24% | 19% | 9% | 11% | 12% |
Documents
Frequently Asked Questions about DCM Shriram Ltd
What does DCM Shriram Ltd do?
Where is DCM Shriram Ltd (DCMSHRIRAM) listed?
Which sector does DCM Shriram Ltd belong to?
What is the market capitalisation of DCM Shriram Ltd?
What is the PE ratio of DCM Shriram Ltd?
What is the 52-week high and low of DCM Shriram Ltd?
Does DCM Shriram Ltd pay dividends?
What is the Return on Equity (ROE) of DCM Shriram Ltd?
How can I research DCM Shriram Ltd on Tapetide?
Company Information
DCM Shriram is engaged in the business of manufacturing facilities of Fertiliser, Chloro Vinyl & Cement in Kota (Rajasthan) and of Chlor- Alkali in Bharuch (Gujrat).(Source : Company Web-site )